€25.54
5.34% yesterday
Xetra, Jun 30, 05:35 pm CET
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Bayer Stock price

€25.54
+0.80 3.23% 1M
+6.22 32.21% 6M
+6.22 32.21% YTD
-0.64 2.43% 1Y
-31.19 54.98% 3Y
-40.26 61.19% 5Y
-100.02 79.66% 10Y
-2.33 8.35% 20Y
Xetra, Closing price Mon, Jun 30 2025
-1.44 5.34%
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Key metrics

Basic
Market capitalization
€26.5b
Enterprise Value
€60.5b
Net debt
€34.0b
Cash
€5.4b
Shares outstanding
982.4m
Valuation (TTM | estimate)
P/E
negative | 5.54
P/S
0.57 | 0.56
EV/Sales
1.30 | 1.28
EV/FCF
10.47
P/B
0.77
Dividends
DPS
€0.11
Yield 1Y | 5Y
0.43% | 2.74%
Growth 1Y | 5Y
0.00% | -47.66%
Payout 1Y | 3Y
-4.23% | -191.24%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€46.6b | €47.2b
EBITDA
€8.0b | €9.5b
EBIT
€-839.0m
Net Income
€-3.3b | €4.5b
Free Cash Flow
€5.8b
Growth (TTM | estimate)
Revenue
-0.92% | 1.28%
EBITDA
-23.90% | -25.77%
EBIT
-214.77%
Net Income
-4.30% | 277.60%
Free Cash Flow
52.69%
Margin (TTM | estimate)
Gross
53.99%
EBITDA
17.19% | 20.10%
EBIT
-1.80%
Net
-6.98% | 9.60%
Free Cash Flow
12.41%
Financial Health
Equity Ratio
28.78%
Return on Equity
-8.00%
ROCE
-1.03%
ROIC
-1.10%
Debt/Equity
1.21
More
EPS
€-3.31
FCF per Share
€5.88
Short interest
-
Employees
90.59k
Rev per Employee
€510.00k
Show more

Create a Free Account to create an Bayer alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Bayer Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Bayer forecast:

10x Buy
34%
18x Hold
62%
1x Sell
3%

Analyst Opinions

29 Analysts have issued a Bayer forecast:

Buy
34%
Hold
62%
Sell
3%

Financial data from Bayer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
46,579 46,579
1% 1%
100%
- Direct Costs 21,432 21,432
10% 10%
46%
25,147 25,147
9% 9%
54%
- Selling and Administrative Expenses 15,817 15,817
8% 8%
34%
- Research and Development Expense 6,241 6,241
19% 19%
13%
8,005 8,005
24% 24%
17%
- Depreciation and Amortization 8,844 8,844
10% 10%
19%
EBIT (Operating Income) EBIT -839 -839
215% 215%
-2%
Net Profit -3,253 -3,253
4% 4%
-7%

In millions EUR.

Don't miss a Thing! We will send you all news about Bayer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bayer Stock News

Neutral
Reuters
about 16 hours ago
The U.S. Supreme Court asked President Donald Trump's administration on Monday for its views on Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.
Neutral
Reuters
about 16 hours ago
Bayer said on Monday that the U.S. Supreme Court had asked the solicitor general for an opinion in the Durnell case, as the German company seeks clarity from the top U.S. court in litigation related to its weedkiller glyphosate.
AD HOC NEWS
one day ago
Bayer DE000BAY0017 muss sich mit Blick auf eine wegweisende Entscheidung des obersten US-Gerichts in den Rechtsstreitigkeiten um den Unkrautvernichter Glyphosat gedulden.
More Bayer News

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Head office Germany
CEO William Anderson
Employees 90,587
Founded 1863
Website www.bayer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today